Business
- Encephalitis Vaccination Market 2024 Key Indicators: Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products
16 Sep, 2024 - Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
15 Sep, 2024 - United States the End-To-End Vaccine Supply Chain Market By Application
15 Sep, 2024 - Nigeria’s Road To Vaccine Self-sufficiency: The Challenges, Prospects
15 Sep, 2024 - Vaccine Contract Manufacturing Market Size, Share, Trends & Forecast
14 Sep, 2024 - AstraZeneca: Treasury says ‘positive discussions’ ongoing over future of £450m vaccine plant
14 Sep, 2024 - Pediatricians cut back on COVID shots as interest wanes
14 Sep, 2024 - Facing stubborn manufacturing challenges
13 Sep, 2024 - French Vaccine Maker Valneva Raises €61M In Private Placing
13 Sep, 2024 - GSK announces launch of Herpes Zoster vaccine Shingrix in Malaysia
13 Sep, 2024 - Influenza Vaccine Market Set to Double to $13.9 Billion by 2033
13 Sep, 2024 - 13 Million Mpox Vaccines Can Be Produced
13 Sep, 2024 - Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
12 Sep, 2024 - Bavarian Nordic eyes external partnerships in bid to produce tens of millions of mpox vaccine doses
12 Sep, 2024 - Moderna to launch skin cancer vaccine as soon as 2025
12 Sep, 2024 - Sanofi completes build out of $554M pandemic-ready modular plant for vaccines, biologics
12 Sep, 2024 - Bavarian Nordic promises two million mpox vaccines for Africa by end of 2024
12 Sep, 2024 - Brazil vaccine provider Beep raises $18 million, turns profitable
12 Sep, 2024 - GSK says mRNA flu shot shows promise in boost for pipeline
12 Sep, 2024 - Bharat Biotech, Alopexx partner to develop new broad-spectrum vaccine
11 Sep, 2024 - Interview: how we’re working to boost global cholera vaccine supply
11 Sep, 2024 - HK inno.N signs new Covid-19 vaccine supply agreement with Pfizer
11 Sep, 2024 - Colorado pediatricians struggling to get COVID-19 doses
10 Sep, 2024 - French firm Osivax grants rights to KM Biologics to develop and market influenza vaccine in Japan
10 Sep, 2024 - Adult Vaccine Market Forecasts Report and Competitive Landscape 2024-2032 Featuring GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, and CSL
10 Sep, 2024 - GSK Shingles Vaccine Now Available In Malaysia
10 Sep, 2024 - Travel Vaccines Market Projected to See Significant Growth by 2031: Emerging Trends, Key Drivers, and Impact of COVID-19 on Global Travel Demand
10 Sep, 2024 - Big Pharma lacks motive to prep for new pandemics
10 Sep, 2024 - mRNA Vaccine Market Size to Achieve USD 9.6 Billion Revenue by 2034, Real-World Efficacy and Infrastructure Investments Boost Market Dynamics – Exclusive Report by Transparency Market Research, Inc.
09 Sep, 2024
0 Comments